drugset / Trial / NCT01765218

Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy

NCT01765218

Phase 1/2 Terminated 34 enrolled Kristin R Hoffman
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal is to see whether topiramate (an anti-epileptic agent) improves the outcome of babies with neonatal hypoxic encephalopathy who are receiving whole body cooling.

Timeline

Start
2013-02
Primary completion
2022-01-27
Completion
2022-01-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Topiramate Small molecule 5 mg/kg Other